Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Julie Kim Insider Profile
4 Followers
Julie Kim, Divisional President at Takeda Pharmaceutical Co, holds ― shares in Takeda Pharmaceutical Co (Ticker: TKPHF).
Julie Kim Takeda Pharmaceutical Co (TKPHF)Divisional President
Takeda Pharmaceutical Co (TKPHF)
Divisional President
Ranked #46,301 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+5.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Julie Kim does not currently own shares as a corporate insider.
A breakdown of Julie Kim's holdings
Insider Roles
Divisional President
Roles that Julie Kim holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 11, 2023 - Today
Return:+16.90%
The most profitable trade made by Julie Kim
Julie Kim's Trading History
List of latest transactions for each holding click on a transaction to see Julie Kim's performance on stock
You May Also Like
Julie Kim insider profile FAQ
What is the percentage of profitable transactions made by Julie Kim?
The percentage of profitable transactions made by Julie Kim is 50%.
What is the average return per transaction made by Julie Kim?
The average return per transaction made by Julie Kim is 5.10%.
What stocks does Julie Kim hold?
Julie Kim holds: TKPHF stocks.
What was Julie Kim’s latest transaction?
Julie Kim latest transaction was an Uninformative Buy of ―.
What was Julie Kim's most profitable transaction?
Julie Kim’s most profitable transaction was an Informative Sell of TKPHF stock on July 11, 2023. The return on the trade was 16.90%.
What is Julie Kim's role in Takeda Pharmaceutical Co?
Julie Kim's role in Takeda Pharmaceutical Co is Divisional President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.